Cargando…
Exploiting B Cell Transfer for Cancer Therapy: Engineered B Cells to Eradicate Tumors
Nowadays, cancers still represent a significant health burden, accounting for around 10 million deaths per year, due to ageing populations and inefficient treatments for some refractory cancers. Immunotherapy strategies that modulate the patient’s immune system have emerged as good treatment options...
Autores principales: | Page, Audrey, Hubert, Julie, Fusil, Floriane, Cosset, François-Loïc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468294/ https://www.ncbi.nlm.nih.gov/pubmed/34576154 http://dx.doi.org/10.3390/ijms22189991 |
Ejemplares similares
-
Engineering B cells with customized therapeutic responses using a synthetic circuit
por: Page, Audrey, et al.
Publicado: (2023) -
Efficient adoptive transfer of autologous modified B cells: a new humanized platform mouse model for testing B cells reprogramming therapies
por: Page, Audrey, et al.
Publicado: (2021) -
Towards Physiologically and Tightly Regulated Vectored Antibody Therapies
por: Page, Audrey, et al.
Publicado: (2020) -
Toward Tightly Tuned Gene Expression Following Lentiviral Vector Transduction
por: Page, Audrey, et al.
Publicado: (2020) -
A fusion peptide in preS1 and the human protein disulfide isomerase ERp57 are involved in hepatitis B virus membrane fusion process
por: Pérez-Vargas, Jimena, et al.
Publicado: (2021)